YSYurii Shulha

Yurii Shulha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yurii Shulha has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Oxazoles as potential anticancer agents: synthesis, in vitro, in silico studies and structure-activity relationship

    by Maryna V. Kachaeva, Oksana S. Bahrieieva, Oleksandr L. Kobzar, Yurii V. Shulha, Oleksiy D. Kachkovsky, Oleksandr P. Kozachenko, Volodymyr S. Brovarets

    A series of 4-unsubstituted, 4-phosphorylated, and 4-cyano-substituted 1,3-oxazoles was evaluated for anticancer screening. Compounds with acceptor substituents in the positions 4 and 5 of azole ring inhibit the growth of a series of NCI-60 panel cancer cell lines, and compounds with donor -SR substituents and -H in the position 5 do not practically inhibit the growth of cancer lines. The quantum‐chemical modeling of model and synthesized oxazole molecules was performed to study steric and electronic properties that may determine the manifestation of anticancer activity. The donor/acceptor properties of 1,3‐oxazoles were evaluated using parameter φ0, which takes into account the relative position of the HOMO and LUMO levels. In silico evaluating of the binding energies of three 1,3-oxazoles to the orthosteric sites of receptors CB2 and A3AR was estimated, and the contribution of different types of substrate-biomolecule interactions was assessed. Calculations show a significant change in the φ0 value upon replacement of the donor substituent at position 5 of the oxazole with hydrogen and the acceptor sulfinyl or sulfonyl substituents. This correlates with the corresponding change in bioactivity, which increases upon substitution from donor to acceptor group at position 5 of the oxazoles. The obtained in silico and in vitro results of the compounds activity proved the perspective of further study of oxazoles as effective anticancer agents

  • Antibacterial Activity and Cytotoxicity Evaluation of 5‐Amino‐4‐cyano‐1,3‐oxazole Derivatives: Synthesis, In Silico, and In Vitro Studies

    by Diana Hodyna, Maryna Kachaeva, Yurii Shulha, Olena Trokhimenko, Vasyl Kovalishyn, Volodymyr Brovarets, Larysa Metelytsia

    Bacterial infections contribute to many human diseases and cancer development, and their increasing incidence, together with rising antimicrobial resistance, underscores the urgent need for new potent biologically active compounds. Quantitative structure‐activity relationship (QSAR) modeling was conducted to evaluate a series of oxazole derivatives as antibacterials. Eighteen new 5‐amino‐4‐cyano‐1,3‐oxazoles with promising predictive properties were synthesized and reliably characterized. Fourteen compounds were found to inhibit bacterial growth (MICs varied from 8 to 512 µg/mL). Eight derivatives exhibited the highest activity against colistin‐resistant Escherichia coli and Staphylococcus aureus isolates with MICs of 8–64 µg/mL. Moreover, six compounds exhibited activities greater or similar to that of reference oxacillin and cefepime against clinical isolates. Analysis of the studied 5‐amino‐4‐cyano‐1,3‐oxazoles as target‐directed glutathione S‐transferase (GST) inhibitors showed that derivatives 7 , 11 , and 12 inhibited GSTA1‐1 with an IC 50 range of 3.2–7.5 µM. Molecular docking results indicate that these compounds can occupy the enzyme's active site. The cytotoxicity results in L20B and RD cell lines showed that compounds 11 and 12 demonstrated significant cytostatic effects, with CD 50 values ranging from 0.02 to 2 µg/mL. Additionally, these two compounds showed moderate acute toxicity toward D. magna, with LC 50 values of 7.27 ± 1.22 and 5.10 ± 1.07 mg/L (D.R. Passino classification).


  • Open Access

    Inhibition of glutathione S-transferases A1-1 and P1-1 by pyrazolone-containing 4-(5-substituted furan-2-yl)benzoic acids

    by Yurii V. Shulha, Oleksandr L. Kobzar, Stepan G. Pilyo, Andriy I. Vovk

    4-(5-Substituted furan-2-yl)benzoic acids with a pyrazolone moiety were evaluated in vitro as inhibitors of human cytosolic glutathione S-transferases A1-1 and P1-1, which are involved in cellular mechanisms of drug resistance and carcinogenesis. When inhibiting GSTA1-1, the compounds demonstrated micromolar and nanomolar IC50 values depending on the nature of the substituent at position 3 of the pyrazolone ring. In particular, the inhibition was increased when the methyl group was replaced by a trifluoromethyl, phenyl, 4-fluorophenyl, thiophen-2-yl, or pyridin-4-yl substituent. The effect of the 4-(5-substituted furan-2-yl)benzoic acids on GSTP1-1 was approximately an order of magnitude lower than that on GSTA1-1. In both cases, the compound bearing a 1-phenyl-3-(4-nitrophenyl)-substituted pyrazolone moiety demonstrated the best inhibitory activity among the derivatives studied. Molecular docking results indicated that the inhibitors interact with GSTA1-1 mainly due to the participation of amino acid residues from the G-site, while in the case of GSTP1-1 the compounds bind to the H-site

  • Synthesis and Anticancer Activity Study of New Bis‐1,3‐Oxazole‐5‐Sulfonylamides

    by Maryna Kachaeva, Stepan Pilyo, Diana Hodyna, Yurii Shulha, Volodymyr Brovarets

    In the present study, eight novel substituted 4‐cyano‐ N ‐(4‐cyano‐1,3‐oxazol‐5‐yl)‐ N ‐alkyl‐1,3‐oxazole‐5‐sulfonylamides have been synthesized. Compounds are characterized by IR, 1 H, 13 C NMR spectroscopy, elemental analysis, and chromato‐mass‐spectrometry. The anticancer activities of six compounds are evaluated against the NCI‐60 human tumor cell line panel. The tested compounds exhibit the strongest antiproliferative (TGI) and cytotoxic (LC 50 ) activities within the leukemia, non‐small‐cell lung cancer, melanoma, and colon cancer subpanels. Overall, the mean activity parameters (GI 50 , TGI, and LC 50 ) calculated for three compounds do not differ significantly and are within the range of 1–100 µM, and for some lines, it reaches the value 10 −8 mol L −1 . Structure–activity relationship analysis reveals markedly higher activity for bisoxazole derivatives bearing 4‐MeC 6 H 4 or 4‐FC 6 H 4 at the second position of the oxazole rings (compounds 2 , 3 , and 7 ), whereas derivatives with diphenyl, di‐tolyl substituents (compounds 1 and 6 ), or 4‐ClC 6 H 4 (compound 8 ) exhibit substantially lower anticancer activity. In addition, the potential molecular mechanisms of anticancer action of these compounds are investigated using molecular docking methods. Derivatives show the highest affinity for tubulin and cyclin‐dependent kinases. Docking of 4‐cyano‐ N ‐[4‐cyano‐2‐(4‐fluorophenyl)‐1,3‐oxazol‐5‐yl]‐ N ‐methyl‐2‐(4‐methylphenyl)‐1,3‐oxazole‐5‐sulfonamide into the colchicine‐binding site of αβ‐tubulin reveals a binding affinity of −10.9 kcal mol −1 , with the ligand located at the subunit interface.


  • In Silico and In Vitro Studies of 1,3‐Oxazol‐4‐yl Phosphonium Salts as Dual‐Functional Antibacterial and Anticancer Agents

    by Diana Hodyna, Oksana Bahrieieva, Yurii Shulga, Vasyl Kovalishyn, Oleksandr Golovchenko, Oksana Golovchenko, Maryna Kachaeva, Stepan Pilyo, Olena Trokhimenko, Larysa Metelytsia, et al.

    This report presents a comprehensive overview of the meticulous construction of a series of classification structure–activity relationship (SAR) models. These models are specifically designed to accurately predict the antibacterial activity of untested compounds against Acinetobacter baumannii . The binary models are based on 1687 chemicals and demonstrate a broad applicability domain for the structures for which they were designed. External validation with a test set confirms the models' capability to accurately predict the activity of newly designed compounds within the applicable range, achieving an accuracy of 78%–84%. The models were used to perform a virtual screening of a chemical library for compounds expected to be active against Acinetobacter baumannii . Six of the most promising compounds were synthesized and evaluated in vitro to assess their antibacterial activity. All tested molecules revealed high anti‐ A. baumannii activity. Our findings indicate that 3‐oxazol‐4‐yl phosphonium salts demonstrate significant cytotoxicity. Notably, these compounds have been identified as potent anticancer agents, exhibiting IC 50 values ranging from 0.005 to 11.49 µM against the HEp‐2 cell line.


  • Synthesis and structure of thiacalix[4]arene phosphoric acids and their ability to inhibit protein tyrosine phosphatases

    by Oleg Silenko, Serhii Cherenok, Oleksandr Kobzar, Yurii Shulha, Eduard Rusanov, Yevgen Karpichev, Andriy Drapailo, Andriy Vovk, Vitaly Kalchenko


  • Open Access

    Antifungal Activity and Cytotoxicity of Imidazole- and Morpholine-Based Lysosomotropic Detergents

    by Diana Hodyna, Vasyl Kovalishyn, Yurii Shulha, Olena Trokhimenko, Olesya Aksenovska, Sergiy Rogalsky, Larysa Metelytsia

    Background. The spread of infectious diseases caused by drug-resistant bacteria and fungi, especially nosoco­mial strains, is currently considered a serious medical problem. It is known that the fungus Candida albicans is the most common causative agent of candidal infection, including the severe type. The emergence and rapid formation of drug resistance, as a risk factor in the treatment of oncological diseases burdened by candidal infection, requires new therapeutic approaches, including the study of synthetic bioregulators with antifungal and anticancer efficacy. Objective. To synthesize and to determine the antifungal activity and cytotoxicity of imidazole- and morpholine-based lysosomotropic detergents (LDs) comprising both dodecyl radicals and ester-functionalized long alkyl chains. Methods. To develop the QSAR models by the OCHEM platform, machine learning methods such as Transfor­mer Convolutional Neural Network (Trans-CNN), Transformer Convolutional Neural Fingerprint (Trans-CNF), and Random Forest (RF) were used. Imidazole- and morpholine-based lysosomotropic detergents comprising both dodecyl radicals and ester-functionalized long alkyl chains were synthesized and characterized by 1H Nuclear Magnetic Resonance spectroscopy. The antifungal properties of studied compounds were estimated by the disc diffusion method against the C. albicans ATCC 10231, C. albicans, C. glabrata and C. krusei clinical isolates. The in vitro cytotoxic activity of LDs was evaluated by IC50 value against the throat cancer HEp-2 cell lines. AutoDock Vina software was used for the evaluation of the synthesis compounds as ligands of several antifungal targets. Results. The identified and synthesized imidazole- and morpholine-based LDs showed high antifungal potential against all Candida spp., specifically against the fluconazole-resistant C. albicans, C. glabrata, and C. krusei clinical isolates. Imidazole-based LD 1 (IM-C12) and morpholine-based LD 4 (Mor-C12) were the most active against tested fungal strains. Molecular docking results suggest that the antifungal mechanisms of the compounds may be related to the inhibition of fungal lanosterol 14a-demethylase. The cytotoxic results of the synthesized compounds against the HEp-2 cell line demonstrated that morpholine-based LDs are less cytotoxic compared to imidazole-based Conclusions. It was found that LD IM-C12 (1) is the most promising cytostatic and antifungal agent based on the obtained results. LDs IM-CH2COOC10 (2) and Mor-C12 (4), which, under conditions of chemical modifi­cation, including through the carbon chain, may also be interesting for developing potential anticancer agents.


  • In Silico Design and In Vitro Assessment of Bicyclic Trifluoromethylated Pyrroles as New Antibacterial and Antifungal Agents

    by Diana Hodyna, Anton Klipkov, Maryna Kachaeva, Yurii Shulha, Igor Gerus, Larysa Metelytsia, Vasyl Kovalishyn

    QSAR studies on the number of compounds tested as S. aureus inhibitors were performed using an interactive Online Chemical Database and Modeling Environment (OCHEM) web platform. The predictive ability of the developed consensus QSAR model was q2=0.79±0.02. The consensus prediction for the external evaluation set afforded high predictive power (q2=0.82±0.03). The models were applied to screen a virtual chemical library with anti‐S. aureus activity. Six promising new bicyclic trifluoromethylated pyrroles were identified, synthesized and evaluated in vitro against S. aureus, E. coli, and A. baumannii for their antibacterial activity and against C. albicans, C. krusei and C. glabrata for their antifungal activity. The synthesized compounds were characterized by 1H, 19F, and 13C NMR and elemental analysis. The antimicrobial activity assessment indicated that trifluoromethylated pyrroles 9 and 11 demonstrated the greatest antibacterial and antifungal effects against all the tested pathogens, especially against multidrug‐resistant strains. The acute toxicity of the compounds to Daphnia magna ranged from 1.21 to 33.39 mg/L (moderately and slightly toxic). Based on the docking results, it can be suggested that the antibacterial and antifungal effects of the compounds can be explained by the inhibition of bacterial wall component synthesis.


  • In Silico, in Vitro and in Vivo Study of Substituted Imidazolidinone Sulfonamides as Antibacterial Agents

    by Diana Hodyna, Vasyl Kovalishyn, Maryna Kachaeva, Yurii Shulha, Anton Klipkov, Elena Shaitanova, Oleksandr Kobzar, Oleh Shablykin, Larysa Metelytsia

    New substituted imidazolidinone sulfonamides have been developed using a rational drug design strategy. Predictive QSAR models for the search of new antibacterials were created using the OCHEM platform. Regression models were applied to verify a virtual chemical library of new imidazolidinone derivatives designed to have antibacterial activity. A number of substituted imidazolidinone sulfonamides as effective antibacterial agents were identified by QSAR prediction, synthesized and characterized by spectral and elemental, and tested in vitro. Six studied compounds have shown the highest in vitro antibacterial activity against Gram‐negative E. coli and Gram‐positive S. aureus multidrug‐resistant strains. The in vivo acute toxicity of these imidazolidinone sulfonamides based on the LC50 value ranged from 16.01 to 44.35 mg/L (slightly toxic compounds class). The results of molecular docking suggest that the antibacterial mechanism of the compounds can be associated with the inhibition of post‐translational modification processes of bacterial peptides and proteins.


  • Open Access

    Inhibition of glutathione S-transferases by calix[4]arene-based phosphinic acids

    by Oleksandr L. Kobzar, Yuriy V. Shulha, Vladyslav M. Buldenko, Andriy B. Drapailo, Vitaly I. Kalchenko, Andriy I. Vovk

    Calix[4]arene-, thiacalix[4]arene- and sulfonylcalix[4]arene-based derivatives with upper rim phosphinic acid groups were studied as inhibitors of glutathione S-transferases. It was found that the macrocyclic compounds can exhibit good to potent activity against GST from equine liver and human recombinant GSTA1-1, while being selective over the enzyme from human placenta and GSTP1-1. The thiacalix[4]arene phosphinic acid was the most active inhibitor of equine liver GST and GSTA1-1 with IC50 values of 85 nM and 50 nM, respectively. Kinetic studies revealed that the inhibition was of non-competitive type concerning both enzyme substrates, glutathione, and 1-chloro-2,4-dinitrobenzene. Molecular docking was carried out to predict possible binding sites for thiacalix[4]arene-based phosphinic acid on the surface of homodimeric GSTA1-1